Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1996; 27:528-535
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aronson, D
Right arrow Articles by Rayfield, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aronson, D
Right arrow Articles by Rayfield, E.

Potential mechanisms promoting restenosis in diabetic patients

D Aronson, Z Bloomgarden, and EJ Rayfield

Department of Medicine, Mount Sinai Medical Center, New York, NY 10029, USA.

Diabetes is associated with greater restenosis rates after successful balloon angioplasty. The metabolic alterations that occur as a result of hyperglycemia or hyperinsulinemia can accelerate many of the pathophysiologic processes that lead to restenosis. Diabetes results in endothelial dysfunction and accelerated platelet deposition, which increase the propensity to thrombosis. Several growth factors known to promote the restenosis process are overexpressed in the presence of hyperglycemia. Advanced glycosylation promotes inflammatory cell recruitment and smooth muscle cell proliferation. Many of the potential mechanisms promoting restenosis in diabetic patients can be ameliorated by improved metabolic control.


This article has been cited by other articles:


Home page
ICVTSHome page
O. Soran, A. Manchanda, and S. Schueler
Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective
Interactive CardioVascular and Thoracic Surgery, June 1, 2009; 8(6): 666 - 671.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
C. Hage, A. Norhammar, L. Grip, K. Malmberg, N. Sarkar, B. Svane, and L. Ryden
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study
Diabetes and Vascular Disease Research, April 1, 2009; 6(2): 71 - 79.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
J. Daemen, K. H. Kuck, C. Macaya, V. LeGrand, M. Vrolix, D. Carrie, I. Sheiban, M. J. Suttorp, P. Vranckx, T. Rademaker, et al.
Multivessel Coronary Revascularization in Patients With and Without Diabetes Mellitus: 3-Year Follow-Up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) Trial
J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1957 - 1967.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Daemen, E. Boersma, M. Flather, J. Booth, R. Stables, A. Rodriguez, G. Rodriguez-Granillo, W. A. Hueb, P. A. Lemos, and P. W. Serruys
Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials
Circulation, September 9, 2008; 118(11): 1146 - 1154.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Daemen and P. W. Serruys
Drug-Eluting Stent Update 2007: Part II: Unsettled Issues
Circulation, August 21, 2007; 116(8): 961 - 968.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Raman, I. Krukovets, T. E. Marinic, P. Bornstein, and O. I. Stenina
Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells
J. Biol. Chem., February 23, 2007; 282(8): 5704 - 5714.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Daemen, H. M. Garcia-Garcia, N. Kukreja, F. Imani, P. P.T. de Jaegere, G. Sianos, R. T. van Domburg, and P. W. Serruys
The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus
Eur. Heart J., January 1, 2007; 28(1): 26 - 32.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
V. G. Cin, H. Pekdemir, M. N. Akkus, A. Camsari, O. Doven, and S. Yenihan
Cutting Balloon Angioplasty for the Treatment of In-Stent Restenosis in Diabetics: A Matched Comparison of 6 Months' Outcome With Conventional Balloon Angioplasty
Angiology, August 1, 2006; 57(4): 445 - 452.
[Abstract] [PDF]


Home page
HeartHome page
S J Hong, M H Kim, T H Ahn, Y K Ahn, J H Bae, W J Shim, Y M Ro, and D-S Lim
Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes
Heart, August 1, 2006; 92(8): 1119 - 1124.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
V K Bhatia and C Di Mario
Darwin and the survival of the fittest in modern interventional cardiology
Heart, August 1, 2006; 92(8): 1017 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ii, H. Takenaka, J. Asai, K. Ibusuki, Y. Mizukami, K. Maruyama, Y.-s. Yoon, A. Wecker, C. Luedemann, E. Eaton, et al.
Endothelial Progenitor Thrombospondin-1 Mediates Diabetes-Induced Delay in Reendothelialization Following Arterial Injury
Circ. Res., March 17, 2006; 98(5): 697 - 704.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. M Franks and S. F Gardner
AGI-1067: A Novel Vascular Protectant for Prevention of Restenosis
Ann. Pharmacother., January 1, 2006; 40(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
B. H Trichon and M. T Roe
Acute coronary syndromes and diabetes mellitus
Diabetes and Vascular Disease Research, May 1, 2004; 1(1): 23 - 32.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. Mehran, G. D. Dangas, Y. Kobayashi, A. J. Lansky, G. S. Mintz, E. D. Aymong, M. Fahy, J. W. Moses, G. W. Stone, and M. B. Leon
Short- and long-term results after multivessel stenting in diabetic patients
J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1348 - 1354.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Chaves, A. G.M.R. Sousa, L. A. Mattos, A. Abizaid, R. Staico, F. Feres, M. Centemero, L. F. Tanajura, A. Abizaid, I. Pinto, et al.
Volumetric Analysis of In-Stent Intimal Hyperplasia in Diabetic Patients Treated With or Without Abciximab: Results of the Diabetes Abciximab steNT Evaluation (DANTE) Randomized Trial
Circulation, February 24, 2004; 109(7): 861 - 866.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. E.J. West, P. N. Ruygrok, C. M.C. Disco, M. W.I. Webster, W. K. Lindeboom, W. W. O'Neill, N. F. Mercado, and P. W. Serruys
Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients
Circulation, February 24, 2004; 109(7): 867 - 873.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Norhammar, K. Malmberg, E. Diderholm, B. Lagerqvist, B. Lindahl, L. Ryden, and L. Wallentin
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization
J. Am. Coll. Cardiol., February 18, 2004; 43(4): 585 - 591.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Mathew, B. J. Gersh, B. A. Williams, W. K. Laskey, J. T. Willerson, R. T. Tilbury, B. R. Davis, and D. R. Holmes Jr
Outcomes in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era: A Report From the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial
Circulation, February 3, 2004; 109(4): 476 - 480.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Roffi and E. J. Topol
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
Eur. Heart J., February 1, 2004; 25(3): 190 - 198.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. A. Corpus, P. B. George, J. A. House, S. R. Dixon, S. C. Ajluni, W. H. Devlin, G. C. Timmis, M. Balasubramaniam, and W. W. O'Neill
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 8 - 14.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Kornowski and S. Fuchs
Optimization of glycemic control and restenosis prevention in diabetic patients undergoing percutaneous coronary interventions
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 15 - 17.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. T. Hurst and R. W. Lee
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
Ann Intern Med, November 18, 2003; 139(10): 824 - 834.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Lincoff
Important Triad in Cardiovascular Medicine: Diabetes, Coronary Intervention, and Platelet Glycoprotein IIb/IIIa Receptor Blockade
Circulation, March 25, 2003; 107(11): 1556 - 1559.
[Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
S. P Marso
Review: The pathogenesis of type 2 diabetes and cardiovascular disease
The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 350 - 356.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
S. P. Marso
Optimizing the diabetic formulary: beyond aspirin and insulin
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 652 - 661.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Mathew and D. R. Holmes
Outcomes in diabetics undergoing revascularization: The long and the short of it
J. Am. Coll. Cardiol., August 7, 2002; 40(3): 424 - 427.
[Full Text] [PDF]


Home page
CirculationHome page
S. C. Smith Jr, D. Faxon, W. Cascio, H. Schaff, T. Gardner, A. Jacobs, S. Nissen, and R. Stouffer
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in Diabetic Patients
Circulation, May 7, 2002; 105 (18): e165 - e169.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
G. Heper, T. Durmaz, S. Namik Murat, and E. Ornek
Clinical and Angiographic Outcomes of Diabetic Patients After Coronary Stenting: A Comparison of Native Vessel Stent Restenosis Rates in Different Diabetic Subgroups
Angiology, May 1, 2002; 53(3): 287 - 295.
[Abstract] [PDF]


Home page
HeartHome page
A Kapur and I S Malik
Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease?
Heart, May 1, 2002; 87(5): 407 - 409.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Hase, N. Joki, M. Nakamura, T. Tsunoda, Y. Tanaka, M. Fukazawa, Y. Takahashi, Y. Imamura, R. Nakamura, and T. Yamaguchi
Favourable long-term outcome by repeated percutaneous coronary revascularization in diabetic haemodialysis patients
Nephrol. Dial. Transplant., January 1, 2002; 17(1): 100 - 105.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. J. Magee, T. M. Dewey, T. Acuff, J. R. Edgerton, J. F. Hebeler, S. L. Prince, and M. J. Mack
Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass
Ann. Thorac. Surg., September 1, 2001; 72(3): 776 - 781.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Indolfi, D. Torella, L. Cavuto, A. M. Davalli, C. Coppola, G. Esposito, M. V. Carriero, A. Rapacciuolo, E. Di Lorenzo, E. Stabile, et al.
Effects of Balloon Injury on Neointimal Hyperplasia in Streptozotocin-Induced Diabetes and in Hyperinsulinemic Nondiabetic Pancreatic Islet-Transplanted Rats
Circulation, June 19, 2001; 103(24): 2980 - 2986.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S.-i. Yamagishi, D. Edelstein, X.-l. Du, and M. Brownlee
Hyperglycemia Potentiates Collagen-Induced Platelet Activation Through Mitochondrial Superoxide Overproduction
Diabetes, June 1, 2001; 50(6): 1491 - 1494.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
T. Takagi, T. Akasaka, A. Yamamuro, Y. Honda, T. Hozumi, S. Morioka, and K. Yoshida
Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular ultrasound study
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1529 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Takagi, K. Yoshida, T. Akasaka, S. Kaji, T. Kawamoto, Y. Honda, A. Yamamuro, T. Hozumi, and S. Morioka
Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: A serial intravascular ultrasound study
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Hammoud, J.-F. Tanguay, and M. G. Bourassa
Management of coronary artery disease: therapeutic options in patients with diabetes
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 355 - 365.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. B. King III
Acute myocardial infarction: are diabetics different?
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1513 - 1515.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Schofer, M. Schluter, T. Rau, F. Hammer, N. Haag, and D. G. Mathey
Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1554 - 1559.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Indolfi, A. Cioppa, E. Stabile, E. Di Lorenzo, G. Esposito, A. Pisani, A. Leccia, L. Cavuto, A. M. Stingone, A. Chieffo, et al.
Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. P. Marso, A. M. Lincoff, S. G. Ellis, D. L. Bhatt, J.-F. Tanguay, N. S. Kleiman, T. Hammoud, J. E. Booth, S. K. Sapp, and E. J. Topol
Optimizing the Percutaneous Interventional Outcomes for Patients With Diabetes Mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) Diabetic Substudy
Circulation, December 21, 1999; 100(25): 2477 - 2484.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. R. Moreno, J. T. Fallon, A. M. Murcia, M. N. Leon, H. Simosa, V. Fuster, and I. F. Palacios
Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1045 - 1049.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Van Belle, K. Abolmaali, C. Bauters, E. P. McFadden, J.-M. Lablanche, and M. E. Bertrand
Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 476 - 485.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Elezi, A. Kastrati, J.u. Pache, A. Wehinger, M. Hadamitzky, J. Dirschinger, F.-J. Neumann, and A. Schomig
Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1866 - 1873.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Ribichini, G. Steffenino, A. Dellavalle, A. Vado, V. Ferrero, T. Camilla, S. Giubergia, and E. Uslenghi
Plasma Lipoprotein(a) Is Not a Predictor for Restenosis After Elective High-Pressure Coronary Stenting
Circulation, September 22, 1998; 98(12): 1172 - 1177.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Abizaid, R. Kornowski, G. S. Mintz, M. K. Hong, A. S. Abizaid, R. Mehran, A. D. Pichard, K. M. Kent, L. F. Satler, H. Wu, et al.
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
J. Am. Coll. Cardiol., September 1, 1998; 32(3): 584 - 589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Ribichini, G. Steffenino, A. Dellavalle, G. Matullo, E. Colajanni, T. Camilla, A. Vado, G. Benetton, E. Uslenghi, and A. Piazza
Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme : A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis
Circulation, January 20, 1998; 97(2): 147 - 154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. O. Han, D. S. Ettenson, E. W. Y. Koo, and E. R. Edelman
Heparin/heparan sulfate chelation inhibits control of vascular repair by tissue-engineered endothelial cells
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2586 - H2595.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Van Belle, C. Bauters, E. Hubert, J.-C. Bodart, K. Abolmaali, T. Meurice, E. P. McFadden, J.-M. Lablanche, and M. E. Bertrand
Restenosis Rates in Diabetic Patients : A Comparison of Coronary Stenting and Balloon Angioplasty in Native Coronary Vessels
Circulation, September 2, 1997; 96(5): 1454 - 1460.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Kornowski, G. S. Mintz, K. M. Kent, A. D. Pichard, L. F. Satler, T. A. Bucher, M. K. Hong, J. J. Popma, and M. B. Leon
Increased Restenosis in Diabetes Mellitus After Coronary Interventions Is Due to Exaggerated Intimal Hyperplasia: A Serial Intravascular Ultrasound Study
Circulation, March 18, 1997; 95(6): 1366 - 1369.
[Abstract] [Full Text]


Home page
NEJMHome page
J. A. Bittl
Advances in Coronary Angioplasty
N. Engl. J. Med., October 24, 1996; 335(17): 1290 - 1302.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement